Novo Nordisk India partners with Emcure Pharma to commercialise Poviztra® in India as a second brand of Wegovy®
Novo Nordisk India and Emcure Pharma today announced a strategic partnership to launch Poviztra®, semaglutide injection 2.4 mg, in India. The collaboration will strengthen the distribution and marketing of semaglutide for weight loss, particularly through pharmacies and in regions beyond those currently served by Novo Nordisk India. Wegovy® (semaglutide injection 2.4 mg) was launched in India […]




